ℹ️
🇬🇧
Search
Search for publications relevant for "disease-modifying treatments"
disease-modifying treatments
Publication
Class
Person
Publication
Programmes
publication
Disease-modifying treatment approaches in Huntington disease: Past and future
2022 |
First Faculty of Medicine
publication
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS
2017 |
First Faculty of Medicine
publication
Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment
2014 |
First Faculty of Medicine
publication
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study
2019 |
First Faculty of Medicine
publication
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
2023 |
First Faculty of Medicine
publication
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis
2007 |
First Faculty of Medicine
publication
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis
2007 |
Faculty of Physical Education and Sport
publication
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
2023 |
First Faculty of Medicine
publication
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe
2023 |
First Faculty of Medicine
publication
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
2019 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine
publication
Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study
2019 |
Faculty of Medicine in Hradec Králové
publication
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
2021 |
First Faculty of Medicine
publication
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
2023 |
First Faculty of Medicine
publication
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine
2016 |
First Faculty of Medicine
publication
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
2013 |
First Faculty of Medicine
publication
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
2018 |
First Faculty of Medicine
publication
New trends in the treatment of diabetic neuropathy
2012 |
Faculty of Medicine in Pilsen
publication
Preventing lymphocyte migration may mean keeping ahead of multiple sclerosis progression
2021 |
First Faculty of Medicine
publication
Treatment of diabetic neuropathy
2012 |
Faculty of Medicine in Pilsen
publication
Optimal Alzheimer's disease detection and diagnosis under the sex and gender lens: a crucial step towards precision neurology
2021 |
Second Faculty of Medicine
publication
A perspective on multi-target drugs for Alzheimer's disease
2020 |
Publication without faculty affiliation
publication
European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy
2020 |
Second Faculty of Medicine
publication
How does fingolimod (gilenya(R)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
2013 |
First Faculty of Medicine
publication
Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients
2017 |
First Faculty of Medicine
publication
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties
2021 |
Publication without faculty affiliation
publication
The direct costs of multiple sclerosis-study in the Czech Republic
2018 |
Faculty of Medicine in Hradec Králové
publication
Microsatellite Polymorphism in Haem Oxygenase 1 Gene Promoter in Multiple Sclerosis
2012 |
First Faculty of Medicine
publication
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management
2018 |
First Faculty of Medicine
publication
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic
2022 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine
publication
Restrictive cardiomyopathy: definition and diagnosis
2022 |
First Faculty of Medicine